Sami-Sabinsa VP Sales & Marketing Ahmed Khan will be a panelist discussing Supply Chain Threats & Opportunities on Wednesday April 17 from 10:45 – 11:45 at the Education Theatre near the show floor. The speakers will discuss global threats to accessing materials, and what companies can do to minimize disruptions. They will look at India, New Zealand, and other countries increasing their importance in the supply chain.

With growing interest in nutraceutical ingredients to support liver health, Sami-Sabinsa will also emphasize clinically studied LivLonga^®, a unique formulation of three scientifically validated ingredients Curcumin C3 Complex^®, Livinol™ and the bioavailability enhancer BioPerine^®.

Other ingredients from Sami-Sabinsa’s portfolio to be highlighted include:

• Sabroxy^®, a patented extract of Oroxylum indicum bark extract, bio-standardized to a unique set of compounds, Oroxylin-A, baicalein and chrysin. Sabroxy supports healthy cognitive function.
• CurCousin^® a patented, clinically studied brand of Calebin A 99% for metabolic health and healthy weight management.
• LactoSpore^®, Bacillus Coagulans MTCC 5856, the popular clinically validated, GRAS, shelf-stable probiotic.
• Saberry^®, a multifaceted phytonutrient from amla fruit standardized to the powerful antioxidant molecule beta-glucogallin, and clinically studied for blood sugar support.
• C3 Reduct^®, for maintaining organ health, is a cascading antioxidant and shows cumulatively stronger activity compared to parent Curcuminoids.

Many of Sami-Sabinsa’s offerings have GRAS status, making them appropriate for being incorporated into functional foods / beverages.